Analysis of post-hoc of CAIRO5

Arndt Vogel shared on X:

“Prognostic value of total tumor volume in CRC liver metastases. post-hoc of CAIRO5 Tumor total volume, but not RECIST 1.1 is prognostic for survival outcomes
5-yr Os 72% for TTV of 3 mL vs 7% for TTV of 300 mL”

Read further.
Source: Arndt Vogel/X

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.